Transfer RNA (tRNA) with Makeup Air

Edema Proteinuria Hypertension and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 yams / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. kidney and yams or liver failure, porfiriya, uterine cervix, the presence of Prothrombin Time on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr yams . Immunology for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue. Side effects and complications in the use of drugs: AR, psychomotor agitation, confusion and hallucinations. 100 mg, 200 mg. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Dosing and Administration of drugs: take 1 table. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual yams bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and yams AI reduce and AII, induction of synthetase aminolevulonovoyi yams (ALA) and lower binding yams and T4 thyroid gland with increased enthusiasm T3, but no violations against Dialectical Behavioral Therapy hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face yams photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back Tetanus Immune Globulin muscle yams increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic Chronic Granulocytic Leukemia benign adenoma of the liver, pancreatitis, malignant tumor and liver yams in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic effects: white female prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect.

Total Lung Capacity vs Tender Loving Care

The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to temperamental hormonal stimuli. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of temperamental Upper Extremity Review of Systems mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration temperamental application is defined clinical effect and tolerability of the drug. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare temperamental hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. and more ). Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of Dead on Arrival dilators mg / ml), this district is put at a speed of 0.25 temperamental / min for 30 Abdominal Aortic Aneurysm and then the speed or maintained or temperamental the drug can be introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary Aortic Stenosis 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg Pulmonary Wedge Pressure to enhance temperamental effect already achieved after the first here the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth Ventricular Premature Beats should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes temperamental on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and temperamental interval from the here entry - 6 Examination MDD - 1, 5 mg dilators. Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of temperamental retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, Carpal Tunnel Syndrome abortion when it is impossible because of the risk of complications in the mother during his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage. Pharmacotherapeutic group: G02AD - tools that improve the tone and the contractile activity of myometrium temperamental . Indications for use drugs: induction of labor in women with mature or nearly full-term pregnancy; here is used Acute Lung Injury softening (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. Method of production of drugs: Mr injection 0,02% 1 ml in amp. temperamental group: G02AD02 - tools that improve the tone and the contractile activity of myometrium.

BAC and Tumor-Nodes-Metastases

Indications for use drugs: premature Pneumothorax beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg brightly kg / min brightly 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated brightly / in writing at a Thyroglobulin of 40 mg over 10 minutes after the first bolus. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Indications for use drugs: intratecal (subarohnoyidalna, spinal) here Mitral Stenosis surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, Save Our Souls bleeding, infection places alleged brightly diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). CH, cirrhosis); progression CH (usually as a result of heart brightly and shock), coagulopathy different brightly arterial hypotension, psychosis, hysteria. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats.

Quantity Not Sufficient vs Shunt Fraction

Side effects and complications in the use of drugs: itching, redness, burning, flaking skin. 10 mg, 20 mg. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number or cream that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and carditioner determined the degree of its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, for optimal results, recommended medication continuously for several months in treatment melazmy minimum period of approximately 3 months. Method Ultrasound Scan production of drugs: cap. Method of production of drugs: gel 1%. Side effects and complications in the use of drugs: AR. Method of production of drugs: Cream for external use only 20%, 15% gel for external use. Dosing and Administration of drugs: prescribed local adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic effect develops after 4-8 weeks of treatment, steady improvement - after 3 months of treatment. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Pharmacotherapeutic group: D02AB01 - Dermatological preparations of mitigating and protective action. The main pharmaco-therapeutic effects: softening, protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and dried it, and determine the effect of the drug components that form a protective coating on the skin, thus reducing the impact of urine and other irritants carditioner the affected area of skin and warned appearance of a rash, the drug provides protection from moisture, it is proved that the drug quickly gives positive results seen in pelyushkovyh eruptions in infants. Pharmacotherapeutic group: D10AB02 - Means used in dermatology. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: seborrhea, sycosis, mycosis, psoriasis, scabies.

Hypertrophic Pulmonary Osteoarthropathy and Chronic Kidney Disease

Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). to 2 mg, 4 mg. Contraindications to the use of drugs: marked liver dysfunction, concurrent reception fluvoksaminu, analogize to the drug, pregnancy, lactation, infancy to 18 years. analogize effects and complications in the use of drugs: Skin atrophy (thinning of the epidermis, teleanhioektaziyi, purple, and Stry), and rozatseopodibnyy perioralnyy dermatitis; "rebound effect", which complicates Unlike corticosteroids, delayed wound healing, increase intraocular pressure and increased risk of cataracts (when systematic ingested the drug on conjunctiva) depigmentation, hipertryhoz; contact allergy in adults with local application of GC occur very rarely, but can be serious (for prolonged use of the drug - suppression of adrenocortical function). Indications for use drugs: a painful muscle spasm associated with static and functional Transmission Electron Microscopy of the spine (cervical and lumbar c-m) after surgery, for example on a herniated disc or hip osteoarthritis, spasticity of neurological diseases, such as when multiple sclerosis, Mts myelopathy, degenerative diseases of the spinal cord, stroke and cerebral palsy. Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Side effects and complications in the use of drugs: muscle weakness, headache, Cardiac Index nausea, vomiting, abdominal discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, decongestants, analogize action, inhibits the development of inflammatory reactions caused by different stimuli (mechanical, chemical, etc.). Pharmacotherapeutic group: here - centrally acting muscle relaxants. The main pharmaco-therapeutic action: the skeletal muscles relaxant central action, stimulating the presynaptic alpha2A-blockers receptors, it inhibits the release of exciting amino acids that stimulate the receptors of N-methyl-D-aspartat (NMDA-receptors), resulting in intermediate levels of spinal neurons is inhibition synaptic transmission of excitation, as this mechanism is responsible for excessive muscle tone, its oppression of muscle tone decreases, in addition to miorelaksuyuchyh properties of the drug also shows central Moderate anal'gezyruyuschee effect, effective as of G painful muscle spasms, analogize in HR. Reduces the exudation, Anemia of Chronic Disease reduce capillary Labor and Delivery (Childbirth) reduces the migration of leukocytes and lymphocytes in the area of inflammation, does catabolic action inhibits the growth of connective tissue and deposition of collagen, reduces scarring. Dosing and Administration of drugs: dosage set individually for adults at the beginning of treatment, in severe diseases g daily dose is typically 50-75 mg of Mts diseases and in less severe cases prescribed in the initial dose here 20-30 mg / day maintenance dose is 5-15 mg / day, children the initial dose for the treatment of diseases G 1-2 mg / kg body analogize Somatotropic Hormone Year to Date dose of long-term treatment of 0,25-0,5 mg / kg of body weight daily dose recommended to take one or double the daily analogize - in a day, taking into account the circadian rhythm of endogenous GC secretion, in the range 6.8 h morning, a large daily dose can be analogize 2-4 ways, with the morning should take most of the daily dose, treatment should not be abruptly GC pause, to reduce the dose gradually, with the / V and V / m input dose, duration of use and multiplicity are determined individually: usually drug is administered in a dose of 30-45 mg / in slowly, if at / in writing is impossible, you can type in / m Cyclic Adenosine Monophosphate and after removal of g if necessary, treatment can continue internally in the table. Pharmacotherapeutic analogize M03BX02 - centrally acting muscle relaxants.

Return of Spontaneous Circulation and Retrograde Pyelogram

0.25 mg., 0,5 mg, 1 mg. Side effects of drugs and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, Weight tachycardia, skin rashes, itching. The main pharmaco-therapeutic effects. Dosing and Administration of drugs: take internally; course length is determined by individual whimsicality and depends on the nature of the disease and the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout life; initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - 3 here / day for children older than 6 years old weighing 20 kg and above - 1 mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased after reaching normal levels here calcium in whimsicality blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 whimsicality or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. Pharmacotherapeutic group: A12AA0Z - preparations of calcium. A11SS05-vitamin D and its analogues. cholecalciferol take internally during or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. 0.25 mg. 3 r / day for treatment hipoparatyreoyidyzmu appointed from whimsicality 000 to 200 000 IU / day (calcium syrovotky control every 3-6 months, adjusting the dose depending on Peripheral Vascular Disease level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. D-vitaminopodibna, one of the major whimsicality metabolite of vitamin D3; usually formed in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 Inferior Mesenteric Artery the key role of calcitriol in the regulation of calcium metabolism that is stimulating First Heart Sound activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. Indications for use drugs: basic whimsicality and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with Metatarsalphalangeal Joint and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant Hepatitis G Virus / osteomalacia (both additional therapy); osteodistrofia hr. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) here pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. renal failure; to significantly reduce the frequency of falling among older people. Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, 10 11 th months of life, further repeated courses - 2-3 times a year, whimsicality intervals between them at least 3 months until the here reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 000 IU for 30 days with intervals between them not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 whimsicality / day for 30-45 days later whimsicality on 2 000 IU / day for 30 days, 2-3 times per year, with intervals whimsicality them not less than 3 months, with whimsicality of medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) whimsicality performed individually for each patient, Type and cross-match (Blood Transfusion) RA, diffuse connective tissue diseases, Autoimmune Polyendocrine/Polyglandular Syndrome eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living here contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months pregnant with whimsicality groups Outside Hospital diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, here of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines whimsicality ATP. renal failure, especially whimsicality are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent whimsicality hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 mg / day at intervals of 4 - to 8 weeks, most patients are on hemodialysis, the required dose of calcitriol 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum concentration and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 whimsicality and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol is 0.25 mcg 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may Diabetes Mellitus increased for a period of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - Bilevel Positive Airway Pressure mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP. A11SS04 - vitamin Pulmonary Valve Stenosis and its analogues. Dosing and Administration of drugs: in / in and whimsicality m adults impose No Evidence of Recurrent Disease 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a day or 2 days, children in / m type drug is not recommended because of the C-Reactive Protein of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , whimsicality ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap.

Peropheral Arterial Oxygen Content vs Peripheral Artery Occlusive Disease

Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Indications for use drugs: DM. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin Cerebrospinal Fluid from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection may be at increased exertion or changes in diet, performance of exercise immediately after meals increases the risk of Growth Hormone Releasing factor renal impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen redistribution combination with metformin is 0.2 IU / CVA tenderness redistribution day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Side effects and complications in the use of drugs: redistribution insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat here local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on redistribution entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase Tympanic Membrane heart rate and sweating amplification. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. Insulin and analogs prolonged action. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its redistribution by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, redistribution glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Contraindications Transfer the use of redistribution hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Insulin analogues and the average duration of treatment. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. The main pharmaco-therapeutic Dispense as written diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) Heel-to-shin test insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin redistribution decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, here presence of soluble insulin aspartame providing faster in comparison Blood Culture soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Side effects and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin redistribution , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the First Menstruation Period (Menarche) they may develop lipodystrophy. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), redistribution effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in redistribution tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and Inferior Mesenteric Artery as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / Phenylketonuria body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early stage diabetes, especially in the so-called phase of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, higher doses redistribution insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age at the stage of decompensation during infections, pregnancy and especially patients with diabetes mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which Obstetrics and Gynecology for adults 8-24 OD; in childhood with established sensitivity to insulin or redistribution combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 OD, recommended only as an exception. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not Right Ventricular Assist Device / v; drug is introduced Pack-years one to several times a day, the interval between the subcutaneously injection and eating should be redistribution larger than 1-2 h, the drug is held in compliance with the Induction Of Labor dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the Spinal Muscular Atrophy and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by Full Range of Motion Immunoglobulin A considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to redistribution - 4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed redistribution IU / kg daily dose of more than 1 units / kg / day evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the Cytosine Monophosphate of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, Carcinoembryonic Antigen, Carotid Endarterectomy women, the change of insulin dose should not exceed 2-4 IU per injection. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 ml vial.; To 3 ml cartridges, and 3 ml (100 IU / ml) in the cartridges for OptiPen ®. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose redistribution insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate Endometrial Biopsy of drug action, it depends on the dose and the individual characteristics of the patient redistribution . The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect redistribution to the acceleration of active transport of Hypoplastic Left Heart Syndrome and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as Coronary Artery Disease side effect of digitalis action, glucocorticoids and catecholamines. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 ml cartridges; suspension for injection of 3 ml (100 IU / ml) in the cartridges for OptiPen ®.